DIHEXA Peptide Research
Dihexa (developmental code name PNB-0408), also known as N-hexanoic-Tyr-Ile-(6) aminohexanoic amide, is a small oligopeptide drug derived from angiotensin IV. It is currently being investigated for the treatment of Alzheimer’s disease and other neurological disorders. Dihexa is thought to work by potentiating the activity of hepatocyte growth factor (HGF) at its receptor, c-Met. HGF is […]
DIHEXA Peptide Research Read More »